Safety and Efficacy of a Single Subretinal Injection of rAAV.hCNGA3 in Patients With CNGA3-linked Achromatopsia
Condition:   AchromatopsiaIntervention:   Drug: rAAV.hCNGA3Sponsors:   STZ eyetrial;   University Hospital TuebingenRecruiting - verified November 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2015 Category: Research Source Type: clinical trials

Safety and Efficacy of a Single Subretinal Injection of rAAV.hCNGA3 in Patients With CNGA3-linked Achromatopsia
Condition:   AchromatopsiaIntervention:   Drug: rAAV.hCNGA3Sponsors:   STZ eyetrial;   University Hospital Tuebingen;   Ludwig-Maximilians - University of MunichRecruiting - verified November 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2015 Category: Research Source Type: clinical trials

Safety and Efficacy of a Single Subretinal Injection of rAAV.hCNGA3 in Patients With CNGA3-linked Achromatopsia
Condition:   AchromatopsiaIntervention:   Drug: rAAV.hCNGA3Sponsors:   STZ eyetrial;   University Hospital TuebingenRecruiting - verified November 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2015 Category: Research Source Type: clinical trials

Safety and Efficacy of a Single Subretinal Injection of rAAV.hCNGA3 in Patients With CNGA3-linked Achromatopsia
Condition:   AchromatopsiaIntervention:   Drug: rAAV.hCNGA3Sponsors:   STZ eyetrial;   University Hospital Tuebingen;   Ludwig-Maximilians - University of MunichRecruiting - verified November 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2015 Category: Research Source Type: clinical trials